Pathogenesis and treatment of acid peptic disorders: comparison of proton pump inhibitors with other antiulcer agents.
about
Review article: the pharmacokinetics of rabeprazole in health and disease.Review article: drug interactions with agents used to treat acid-related diseases.Review article: rabeprazole's tolerability profile in clinical trials.Review article: rabeprazole's profile in patients with gastrointestinal diseases.Costs of care for irritable bowel syndrome patients in a health maintenance organization.Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.Novel effects other than antisecretory action and off-label use of proton pump inhibitors.Rabeprazole, 20 mg once daily or 10 mg twice daily, is equivalent to omeprazole, 20 mg once daily, in the healing of erosive gastrooesophageal reflux disease.Rabeprazole: pharmacology, pharmacokinetics, and potential for drug interactions. Introduction.Pharmacokinetics and Excretion Studies on CDRI-85/92, an Antiulcer Proton Pump Inhibitor.New method for long-term monitoring of intragastric pH.Decreasing oesophageal acid exposure in patients with GERD: a comparison of rabeprazole and omeprazole.Rabeprazole: pharmacokinetics and tolerability in patients with stable, end-stage renal failure.
P2860
Q33734843-8C2D49F0-AD23-428D-86D2-FCC7BF513ED2Q33734848-35F646D0-670A-4996-AA69-3AD438D974A5Q33771063-37118455-768B-4012-9F94-68A1D613A700Q33771068-12332521-6E2B-45CE-8E77-699657D8D93DQ34103131-53480E91-6975-4BEB-A2C8-36F44AB0756EQ35923949-41354190-C054-49F9-8107-16A1D3E46781Q36040679-A8CCB9A3-F3A1-4510-844B-4AE80FD51208Q39422116-4212366C-FDF7-4BF9-AAE9-58B09B9B6811Q41691187-34E66BFB-997B-49F2-B590-11D7A009AAC4Q42155198-41A1BFFE-3514-40CD-BF5B-E8CE51C92CFDQ42954885-0B1C6658-461B-4C29-A160-2323424BD7DFQ43734552-58966B9B-5FE8-479B-B5C1-4A1659A8DBD4Q53925847-3E6F58B0-A4FE-40F3-B083-2C77B3DF9E25
P2860
Pathogenesis and treatment of acid peptic disorders: comparison of proton pump inhibitors with other antiulcer agents.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Pathogenesis and treatment of ...... s with other antiulcer agents.
@en
type
label
Pathogenesis and treatment of ...... s with other antiulcer agents.
@en
prefLabel
Pathogenesis and treatment of ...... s with other antiulcer agents.
@en
P1476
Pathogenesis and treatment of ...... s with other antiulcer agents.
@en
P2093
Sanders SW
P304
2-34; discussion 1
P356
10.1016/S0149-2918(96)80175-5
P577
1996-01-01T00:00:00Z